A international team led by scientists from the Genomics Institute of the Novartis Research Foundation (GNF) and The Scripps Research Institute has discovered a family of chemical compounds that could lead to a new generation of antimalarial drugs capable of not only alleviating symptoms but also preventing the deadly disease.
Source:
http://www.sciencedaily.com/releases/2011/11/111117135722.htm
0 comments:
Post a Comment